Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Immune-protective habits, and stopping MS early

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

The four main risk factors account for most of what is known. Behind them is a second tier with weaker but real evidence, and it is worth being clear which is which.

The more useful idea on this page is secondary prevention: for someone who has already had a first episode, or has MS-like lesions found by accident, preventing the next event is where the evidence is strongest.

Related pages: Multiple sclerosis (MS)

The bottom line

What we know
  • Gut bacteria influence immune regulation, and differences are seen in people with MS.
  • Organic solvent exposure is associated with higher MS risk.
  • Early treatment after a first episode delays or prevents a second.
  • Most people with a first-degree relative with MS never develop it.
What is still open
  • Whether changing the gut microbiome affects MS, which trials have not shown.
  • Who with incidental MS-like lesions should be treated, which is actively debated.

The story, step by step

  1. 1. The gut ()
  2. 2. Activity and sleep ()
  3. 3. Solvents ()
  4. 4. After a first episode ()
  5. 5. For relatives ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Microbiome and diet

Review of many studies

What happens

A genuinely interesting area that is routinely oversold.

What the research shows

  • Gut bacteria influence regulatory T cells, the immune cells that restrain autoimmune responses, partly through short-chain fatty acids such as butyrate produced when bacteria ferment fibre.
  • Studies consistently find differences in gut bacterial composition between people with and without MS, and animal models show diet and bacteria can alter disease severity.
  • What has not been shown is that changing the microbiome changes MS in people. Probiotic and faecal transplant trials in MS are small and preliminary.
  • What is reasonable: a diet with plenty of fibre, vegetables, whole grains and fermented foods, which supports bacterial diversity and is good for cardiovascular health regardless.
  • What is not reasonable: expensive microbiome testing, personalized supplement protocols sold on the back of it, or faecal transplant outside a trial.

Why it matters

Eating more fibre is sensible and cheap. Buying a microbiome protocol is neither, and the evidence does not support it.

What's still uncertain

  • Whether microbiome differences cause MS or result from it is unresolved.

Read more

Next: Activity and sleep

Part 2 of 5

Smaller but real

Review of many studies

What happens

Two general health factors with modest associations in MS.

What the research shows

  • Regular aerobic activity lowers inflammatory signalling and raises neurotrophic factors such as BDNF, which support nerve cell survival.
  • Observational cohorts link higher physical activity with lower MS incidence, though people who are already developing symptoms may exercise less, which complicates the picture.
  • Shift work in adolescence and early adulthood has been associated with higher MS risk in several studies, with disrupted melatonin and circadian immune regulation proposed as the mechanism.
  • Chronic short sleep in the same period shows a similar association.
  • These are weaker associations than vitamin D, smoking, weight or EBV, and should be presented as such rather than merged into one list.

Why it matters

Worth doing for general health; not worth anxiety. Someone who worked night shifts at twenty did not give themselves MS.

What's still uncertain

  • These associations are observational and the effect sizes are modest.

Read more

Next: Solvents

Part 3 of 5

The occupational one

Review of many studies

What happens

A less familiar exposure with a reasonably consistent signal.

What the research shows

  • Prolonged inhalation of organic solvents, such as those in paints, varnishes, adhesives and industrial degreasers, has been associated with increased MS risk.
  • The association appears independent of smoking, and the combination of solvent exposure, smoking and the HLA risk genes produces much larger risk estimates than any one alone.
  • This matters for painters, printers, mechanics, people working with fibreglass, and some laboratory and manufacturing roles.
  • Practical protection is the standard occupational approach: ventilation, appropriate respiratory protection rather than a dust mask, and following the safety data sheet for the product.
  • Employers are generally required to provide and maintain this protection, which makes it a workplace issue rather than a personal one.

Why it matters

If someone works with solvents daily, ventilation and proper respiratory protection are worth taking seriously for several reasons, of which MS risk is only one.

What's still uncertain

  • Evidence comes from case-control studies, which are vulnerable to recall bias.

Read more

Next: After a first episode

Part 4 of 5

Where prevention actually works

Review of many studies

What happens

Secondary prevention, and the strongest evidence on this page.

What the research shows

  • Clinically isolated syndrome means a first episode of demyelination that does not yet meet the criteria for MS.
  • Trials show that starting disease-modifying treatment after a first episode delays or prevents the second attack and reduces new lesion formation.
  • Radiologically isolated syndrome is different: MS-like lesions found on a scan done for another reason, in someone with no symptoms. A substantial minority go on to develop MS, with higher risk in younger people, those with spinal cord lesions, and those with oligoclonal bands.
  • Two trials of treatment in radiologically isolated syndrome have shown a reduction in progression to a first clinical event, but who should be treated remains debated, since many people never develop MS and treatments carry risks.
  • Alongside this, managing blood pressure, cholesterol, blood sugar and weight protects the brain from additional injury.

Why it matters

This is the one place where the word prevention is well supported: preventing the second event after the first, not preventing MS from scratch.

What's still uncertain

  • How to select people with incidental lesions for treatment is unresolved.

Read more

Next: For relatives

Part 5 of 5

What to tell family

Review of many studies

What happens

The questions that come up after someone is diagnosed.

What the research shows

  • A child or sibling has a lifetime risk of roughly 2 to 4 percent, against roughly 0.1 to 0.3 percent in the general population. Higher, and still unlikely.
  • There is no genetic test worth having. The known variants are common in people who never develop MS and predict nothing useful for an individual.
  • Screening MRIs for relatives without symptoms are not recommended and frequently cause harm: incidental findings create anxiety and lead to further investigation without changing outcomes.
  • What is reasonable for a family: a smoke-free home, support for healthy weight in teenagers, adequate vitamin D within normal ranges, and knowing which symptoms would be worth checking.
  • Those symptoms are the ones that last more than a day and do not have another explanation: vision loss in one eye, numbness or weakness spreading over hours to days, or new unsteadiness.
  • MS is not caused by anything a person did or failed to do, and relatives should not be left carrying that idea.

Why it matters

The honest summary for relatives: a modest increase in risk, no test worth taking, a few sensible habits, and no cause for routine scanning.

What's still uncertain

  • Prediction at the individual level is not currently possible.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.